We are live on ! Find out more
JGBO

Jiangbo Pharmaceuticals, Inc. Common Stock
JGBO

Delisted

JGBO was delisted on the 31st of May, 2011.

1 hedge funds and large institutions have $19K invested in Jiangbo Pharmaceuticals, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

0% more capital invested

Capital invested by funds: $19K → $19K ($0)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
1
Pope Asset Management
Tennessee
$19K

JGBO Hedge Fund Activity: Q1 2015 in Review

1 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) for Q1 2015, worth a combined $19K — unchanged from a quarter earlier.

Fund positioning in JGBO was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $19K of Jiangbo Pharmaceuticals, Inc. Common Stock stock for Q1 2015, unchanged quarter-over-quarter.
  • 0 funds opened new Jiangbo Pharmaceuticals, Inc. Common Stock positions in Q1 2015 and 0 closed out.

Based on aggregated 13F filings for Q1 2015.